Management of stage III non-small-cell lung cancer: rays of hope
Lung cancer remains the most common cause of cancer death across the world. Non-small-cell lung cancer (NSCLC) represents the most frequent type of lung cancer and is frequently diagnosed at an advanced stage. Stage III NSCLC, which encompasses 30% of cases, refers to a state between localized and m...
Saved in:
Main Authors: | Floryane Kim (Author), Maxime Borgeaud (Author), Alfredo Addeo (Author), Alex Friedlaender (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
by: Giuseppe Luigi Banna, et al.
Published: (2020) -
Immunotherapy in inoperable stage III non-small cell lung cancer: a review
by: Natasha A Jain, et al.
Published: (2019) -
Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
by: Guo D, et al.
Published: (2021) -
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review
by: Laure Thouvenin, et al.
Published: (2021) -
Use of Appendix as Neoureter- A Ray of Hope
by: Parveen Kumar, et al.
Published: (2017)